AAAAAA
Results: 1-25/28
Authors:
Waltenberger, J
Hombach, V
Citation: J. Waltenberger et V. Hombach, Therapeutic angiogenesis for the heart, NEW ANGIOTHERAPY, 2002, pp. 279-293
Authors:
Faehling, M
Koch, ED
Raithel, J
Trischler, G
Waltenberger, J
Citation: M. Faehling et al., Vascular endothelial growth factor-a activates Ca2+-activated K+ channels in human endothelial cells in culture, INT J BIO C, 33(4), 2001, pp. 337-346
Authors:
Boldicke, T
Tesar, M
Griesel, C
Rohde, M
Grone, HJ
Waltenberger, J
Kollet, G
Lapidot, T
Yayon, A
Weich, H
Citation: T. Boldicke et al., Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizingthe human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) onthe surface of primary endothelial cells and preselected. CD34(+) cells from cord blood, STEM CELLS, 19(1), 2001, pp. 24-36
Authors:
Rusnati, M
Urbinati, C
Musulin, B
Ribatti, D
Albini, A
Noonan, D
Marchisone, C
Waltenberger, J
Presta, M
Citation: M. Rusnati et al., Activation of endothelial cell mitogen activated protein kinase ERK1/2 by extracellular HIV-1 Tat protein, ENDOTHELIU, 8(1), 2001, pp. 65-74
Authors:
Taraseviciene-Stewart, L
Kasahara, Y
Alger, L
Hirth, P
McMahon, G
Waltenberger, J
Voelkel, NF
Tuder, RM
Citation: L. Taraseviciene-stewart et al., Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension, FASEB J, 15(2), 2001, pp. 427-438
Authors:
Schneider, E
Schmid-Kotsas, A
Zhao, JS
Weidenbach, H
Schmid, RM
Menke, A
Adler, G
Waltenberger, J
Grunert, A
Bachem, MG
Citation: E. Schneider et al., Identification of mediators stimulating proliferation and matrix synthesisof rat pancreatic stellate cells, AM J P-CELL, 281(2), 2001, pp. C532-C543
Authors:
Waltenberger, J
Citation: J. Waltenberger, The pathophysiological basis of unstable coronary syndromes, HERZ, 26, 2001, pp. 2-8
Authors:
Scheidegger, P
Weiglhofer, WG
Suarez, S
Console, S
Waltenberger, J
Pepper, MS
Jaussi, R
Ballmer-Hofer, K
Citation: P. Scheidegger et al., Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity, BIOCHEM J, 353, 2001, pp. 569-578
Authors:
Skaletz-Rorowski, A
Muller, JG
Kroke, A
Waltenberger, J
Pulawski, E
Pinkernell, K
Breithardt, G
Citation: A. Skaletz-rorowski et al., Lovastatin blocks basic fibroblast growth factor-induced mitogen-activatedprotein kinase signaling in coronary smooth muscle cells via phosphatase inhibition, EUR J CELL, 80(3), 2001, pp. 207-212
Authors:
Kirkin, V
Mazitschek, R
Krishnan, J
Steffen, A
Waltenberger, J
Pepper, MS
Giannis, A
Sleeman, JP
Citation: V. Kirkin et al., Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2, EUR J BIOCH, 268(21), 2001, pp. 5530-5540
Authors:
Waltenberger, J
Citation: J. Waltenberger, Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications, CARDIO RES, 49(3), 2001, pp. 554-560
Authors:
Torzewski, M
Rist, C
Mortensen, RF
Zwaka, TP
Bienek, M
Waltenberger, J
Koenig, W
Schmitz, G
Hombach, V
Torzewski, J
Citation: M. Torzewski et al., C-reactive protein in the arterial intima - Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis, ART THROM V, 20(9), 2000, pp. 2094-2099
Authors:
Fishbein, I
Waltenberger, J
Banai, S
Rabinovich, L
Chorny, M
Levitzki, A
Gazit, A
Huber, R
Mayr, U
Gertz, SD
Colomb, G
Citation: I. Fishbein et al., Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats, ART THROM V, 20(3), 2000, pp. 667-676
Regulation of endothelial function and angiogenesis by vascular endothelial growth factor-A (VEGF-A)
Authors:
Kroll, J
Waltenberger, J
Citation: J. Kroll et J. Waltenberger, Regulation of endothelial function and angiogenesis by vascular endothelial growth factor-A (VEGF-A), Z KARDIOL, 89(3), 2000, pp. 206-218
Authors:
Kranz, A
Rau, C
Kochs, M
Waltenberger, J
Citation: A. Kranz et al., Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance, J MOL CEL C, 32(1), 2000, pp. 65-72
Authors:
Kasahara, Y
Tuder, RM
Taraseviciene-Stewart, L
Le Cras, TD
Abman, S
Hirth, PK
Waltenberger, J
Voelkel, NF
Citation: Y. Kasahara et al., Inhibition of VEGF receptors causes lung cell apoptosis and emphysema, J CLIN INV, 106(11), 2000, pp. 1311-1319
Authors:
Rousseau, S
Houle, F
Kotanides, H
Witte, L
Waltenberger, J
Landry, J
Huot, J
Citation: S. Rousseau et al., Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase, J BIOL CHEM, 275(14), 2000, pp. 10661-10672
Authors:
Waltenberger, J
Lange, J
Kranz, A
Citation: J. Waltenberger et al., Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus - A potential predictor for theindividual capacity to develop collaterals, CIRCULATION, 102(2), 2000, pp. 185
Authors:
Brekken, RA
Overholser, JP
Stastny, VA
Waltenberger, J
Minna, JD
Thorpe, PE
Citation: Ra. Brekken et al., Selective inhibition of vascular endothelial growth factor (VEGF) receptor2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice, CANCER RES, 60(18), 2000, pp. 5117-5124
Authors:
Skaletz-Rorowski, A
Waltenberger, J
Muller, JG
Pawlus, E
Pinkernell, K
Breithardt, G
Citation: A. Skaletz-rorowski et al., Protein kinase C mediates basic fibroblast growth factor-induced proliferation through mitogen-activated protein kinase in coronary smooth muscle cells, ART THROM V, 19(7), 1999, pp. 1608-1614
Authors:
Meyer, M
Clauss, M
Lepple-Wienhues, A
Waltenberger, J
Augustin, HG
Ziche, M
Lanz, C
Buttner, M
Rziha, HJ
Dehio, C
Citation: M. Meyer et al., A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases, EMBO J, 18(2), 1999, pp. 363-374
Authors:
Kranz, A
Mayr, U
Frank, H
Waltenberger, J
Citation: A. Kranz et al., The coronary endothelium: A target for vascular endothelial growth factor.Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo, LAB INV, 79(8), 1999, pp. 985-991
Authors:
Kranz, A
Mattfeldt, T
Waltenberger, J
Citation: A. Kranz et al., Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer, INT J CANC, 84(3), 1999, pp. 293-298
Authors:
Waltenberger, J
Uecker, A
Kroll, J
Frank, H
Mayr, U
Bjorge, JD
Fujita, D
Gazit, A
Hombach, V
Levitzki, A
Bohmer, FD
Citation: J. Waltenberger et al., A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with mitogenic and mitogenic responses to PDGF in vascular smooth muscle cells - A novel candidate for prevention of vascular remodeling, CIRCUL RES, 85(1), 1999, pp. 12-22
Authors:
Kroll, J
Waltenberger, J
Citation: J. Kroll et J. Waltenberger, A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells, BIOC BIOP R, 265(3), 1999, pp. 636-639